Clinical and Pharmacological Effects of Monoamine Precursors or Haloperidol in Chronic Schizophrenia
- 1 March 1968
- journal article
- Published by Springer Nature in Nature
- Vol. 217 (5131), 854
- https://doi.org/10.1038/217854a0
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- TRYPTOPHAN IN THE TREATMENT OF DEPRESSIONThe Lancet, 1967
- 5-HYDROXYTRYPTOPHAN FOR DEPRESSIONThe Lancet, 1967
- ORGANIZED STUDENT PROTEST AND INSTITUTIONAL CLIMATEETS Research Bulletin Series, 1967
- 5-HYDROXYINDOLE COMPOUNDS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH PSYCHIATRIC OR NEUROLOGICAL DISEASESThe Lancet, 1966
- Norepinephrine in Depressive ReactionsArchives of General Psychiatry, 1965
- THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCEAmerican Journal of Psychiatry, 1965
- L-METHIONINE AND L-TRYPTOPHAN FEEDINGS IN NON-PSYCHOTIC AND SCHIZOPHRENIC PATIENTS WITH AND WITHOUT TRANYLCYPROMINEJournal of Nervous & Mental Disease, 1963
- Effects of Amino Acid Feedings in Schizophrenic Patients Treated with IproniazidScience, 1961
- THE ADMINISTRATION OF BAS, 5-HTP, AND MARSILID TO SCHIZOPHRENIC PATIENTSAmerican Journal of Psychiatry, 1959
- Observations on Schizophrenic Patients After Iproniazid and TryptophanArchives of Neurology & Psychiatry, 1958